{"nct_id":"NCT04274907","title":"A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression","status":"TERMINATED","status_verified_date":"2021-02","start_date":"2020-06-30","start_date_type":"ACTUAL","primary_completion_date":"2021-02-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}